François Jacques

1.6k total citations
16 papers, 202 citations indexed

About

François Jacques is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, François Jacques has authored 16 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in François Jacques's work include Multiple Sclerosis Research Studies (10 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). François Jacques is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). François Jacques collaborates with scholars based in Canada, United States and Japan. François Jacques's co-authors include Samuel David, Alexandre Prat, Jennifer L. Berard, Nathalie Arbour, V. Wee Yong, Juan G. Zarruk, Shizuo Akira, Letizia Leocani, Peter Fuhr and Garth Nicholas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

François Jacques

16 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Jacques Canada 6 60 59 57 52 40 16 202
Nadia Ouamara France 8 45 0.8× 130 2.2× 63 1.1× 71 1.4× 27 0.7× 15 256
Seyed Mohammad Baghbanian Iran 9 88 1.5× 132 2.2× 13 0.2× 32 0.6× 32 0.8× 43 236
Saskia Bresch France 10 120 2.0× 96 1.6× 9 0.2× 24 0.5× 38 0.9× 22 240
Jürgen Prestel Germany 9 135 2.3× 29 0.5× 36 0.6× 20 0.4× 126 3.1× 10 365
Johan Mellergård Sweden 10 63 1.1× 215 3.6× 49 0.9× 145 2.8× 88 2.2× 22 394
Sebastian Herich Germany 7 35 0.6× 108 1.8× 82 1.4× 179 3.4× 44 1.1× 7 308
Shuyuan Yue China 11 135 2.3× 19 0.3× 37 0.6× 23 0.4× 154 3.9× 28 405
Tomohiko Uchida Japan 13 181 3.0× 289 4.9× 93 1.6× 90 1.7× 79 2.0× 26 408
Robert W. Freilich United States 4 21 0.3× 23 0.4× 116 2.0× 138 2.7× 108 2.7× 5 394
Ayal Rozenberg Israel 8 31 0.5× 78 1.3× 21 0.4× 89 1.7× 39 1.0× 16 226

Countries citing papers authored by François Jacques

Since Specialization
Citations

This map shows the geographic impact of François Jacques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Jacques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Jacques more than expected).

Fields of papers citing papers by François Jacques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Jacques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Jacques. The network helps show where François Jacques may publish in the future.

Co-authorship network of co-authors of François Jacques

This figure shows the co-authorship network connecting the top 25 collaborators of François Jacques. A scholar is included among the top collaborators of François Jacques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Jacques. François Jacques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jacques, François, et al.. (2023). Motor Evoked Potential—A Pilot Study Looking at Reliability and Clinical Correlations in Multiple Sclerosis. Journal of Clinical Neurophysiology. 41(4). 357–364. 3 indexed citations
2.
Wray, Sibyl, François Jacques, Tamara Miller, et al.. (2022). Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(4). 3090499088–3090499088. 6 indexed citations
3.
Jacques, François, et al.. (2021). Avelumab in newly diagnosed glioblastoma. Neuro-Oncology Advances. 3(1). vdab118–vdab118. 18 indexed citations
4.
Jacques, François, et al.. (2020). Single Digit Modality: What is a Clinically Significant Change in Multiple Sclerosis Patients (880). Neurology. 94(15_supplement). 3 indexed citations
5.
Jacques, François, et al.. (2020). Immunopathogenesis of COVID-19: Summary and Possible Interventions. Frontiers in Immunology. 11. 564925–564925. 21 indexed citations
6.
Wray, Sibyl, François Jacques, Tamara Miller, et al.. (2019). Treatment Sequencing and Satisfaction With Alemtuzumab in Relapsing Multiple Sclerosis Patients: Interim Results of the Real-world PRO-ACT Study (P3.2-097). Neurology. 92(15_supplement). 1 indexed citations
7.
Jacques, François, et al.. (2019). Avelumab in newly diagnosed glioblastoma multiforme: The SEJ study.. Journal of Clinical Oncology. 37(15_suppl). e13571–e13571. 4 indexed citations
8.
Hardmeier, Martin, François Jacques, Philipp Albrecht, et al.. (2019). Multicentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trials. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(2). 17 indexed citations
9.
Hardmeier, Martin, François Jacques, Philipp Albrecht, et al.. (2018). T85. Sensory and motor evoked potentials in a multicenter setting: Definition of significant change in repeated measurements in healthy subjects on individual level. Clinical Neurophysiology. 129. e34–e35. 1 indexed citations
10.
Jacques, François, Garth Nicholas, & Ian Lorimer. (2018). Avelumab in newly diagnosed glioblastoma multiforme: The SEJ study. Annals of Oncology. 29. viii131–viii131. 2 indexed citations
11.
Hardmeier, Martin, François Jacques, Philipp Albrecht, et al.. (2018). F107. Sensory and motor evoked potentials in a multicenter setting: Estimation of detectable group differences at varying sample sizes. Clinical Neurophysiology. 129. e106–e107. 1 indexed citations
12.
Jacques, François, et al.. (2018). Prolonged-Release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: A Pilot, Double-Blind, Randomized, Placebo-Controlled Study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(1). 2453181136–2453181136. 4 indexed citations
13.
Kaushik, Deepak, Heather Yong, Jennifer Hahn, et al.. (2016). Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid. PLoS ONE. 11(10). e0163802–e0163802. 5 indexed citations
14.
Jacques, François, et al.. (2016). Cognitive evolution in natalizumab-treated multiple sclerosis patients. Multiple Sclerosis Journal - Experimental Translational and Clinical. 2. 2451077084–2451077084. 8 indexed citations
15.
Berard, Jennifer L., Juan G. Zarruk, Nathalie Arbour, et al.. (2012). Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia. 60(7). 1145–1159. 103 indexed citations
16.
Jacques, François, et al.. (2012). Combination Therapy of Interferon Beta-1b and Tacrolimus: A Pilot Safety Study. SHILAP Revista de lepidopterología. 2012. 1–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Ouamara Breakdown of academic impact, for papers by Seyed Mohammad Baghbanian Breakdown of academic impact, for papers by Saskia Bresch Breakdown of academic impact, for papers by Jürgen Prestel Breakdown of academic impact, for papers by Johan Mellergård Breakdown of academic impact, for papers by Sebastian Herich Breakdown of academic impact, for papers by Shuyuan Yue Breakdown of academic impact, for papers by Tomohiko Uchida Breakdown of academic impact, for papers by Robert W. Freilich Breakdown of academic impact, for papers by Ayal Rozenberg
Rankless by CCL
2026